Aids and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic

Social Science and Medicine

Volumn 41, Issue 5, 1995, Pages 699-716

  Stimson, Gerry V ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

AIDS; HIV prevalence; injecting drug use; policy; prevention; risk behaviour; United Kingdom

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASIA; DRUG ABUSE; HEALTH BEHAVIOR; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RISK ASSESSMENT; SYRINGE; UNITED KINGDOM; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; COMPARATIVE STUDY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; GREAT BRITAIN; HEALTH POLICY; HUMAN; INCIDENCE; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SUPPORT, NON-U.S. GOV'T;

EID: 0029152815     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-9536(94)00435-V     Document Type: Article

References (123)

1. HTLV-III antibody in Edinburgh drug addicts
2. Epidemic of AIDS-related virus (HTLV-III/LAV) infection among intravenous drug abusers
3. HIV infection in Scotland
4. The Edinburgh epidemic: a case study
5. The global diffusion of injecting drug use: Implications for human immunodeficiency virus infection
6. HTLV-III antibodies in an Edinburgh clinic
7. Why drug users sought help from one London drug clinic
8. Syringe sharing among London drug abusers
9. Drug injecting, AIDS and risk behaviour
10. Risk behaviours for HIV infection among injecting drug users attending a drug dependency clinic
11. Fewer drug users share needles
12. Council Statement
13. Syringe-exchange schemes for drug users in England and Scotland
14. HIV, drugs and public health in England: new words, old tunes
15. The relationship between the State and local practice in the development of national policy on drugs between 1920 and 1989
16. AIDS and HIV: the challenge for British drug services (Fourth Thomas James Okey Lecture)
17. Short-term Prediction of HIV Infection and AIDS in England and Wales
18. The roles of prescribing
19. Intermediate goals and the process of change
20. The impacts of HIV: forcing the process of change
21. Minimising harm from drug use
22. Prevention of AIDS among Drug Misusers: the Role of the High Street Pharmacy
23. The future of syringe-exchange in the public health prevention of HIV infection
24. North West Thames Regional Pharmaceutical Service
25. Out of the Agency and on to the Streets: A Review of HIV Outreach Health Education in Europe and the United States
26. National survey of syringe exchange schemes in England
27. Drugs and social policy: the establishment of drug control in Britain 1900–1930
28. The Impact on Drug Services in England of the Central Funding Initiative
29. Estimates of HIV prevalence and rates of HIV testing among drug injectors in London
30. Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990–1992
31. The importance of multisite sampling in determining the prevalence of HIV among drug injectors in Glasgow and London
32. HIV among south London heroin users in 1991
33. Reduction in needle sharing among community-wide samples of injecting drug users
34. HTLV-III antibody in drug abusers in the west of Scotland the Edinburgh connection
35. Risk taking behaviour on the decline in intravenous drug users
36. The epidemic of HIV infection among injecting drug users in New York City: the first decade and possible future directions
37. Drug injecting and HIV infection among the population of drug abusers in Asia
38. Khanchit Limpakarn Janarat, Kumnuan Ungchusak, Sombat Thanprasertsuk, Kachit Choopanya, Suphak Vanichseni, Thongchai Uneklabh, Prasert Thongchareon and Chantapong Wasi
39. Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980–1989
40. Rapid spread of HIV among injecting drug users in north-eastern states of India
41. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities
42. European Community concerted action on the prevalence and risk factors of HIV infection among injecting drug users, January 1990–June 1991
43. Incidence trends of HIV infection and risk factors for parenteral and sexual transmission in intravenous drug users from Milan and northern Italy
44. Control of HIV Infection in injecting drug users in San Francisco
45. Charting the epidemic: the case study of HIV screening of injecting drug users in San Francisco 1985–1990
46. Epidemiology and Prevention of HIV in Intravenous Drug Users in San Francisco
47. Behaviour change and stabilisation of seroprevalence levels in communities of injecting drug users: correlation or causation
48. Heterosexual behaviour of intravenous drug users in Amsterdam; implications for the AIDS epidemic
49. A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city
50. Syringe-exchange: has it worked?
51. HIV risk behaviour of clients attending syringe-exchange schemes in England and Scotland
52. Changes in risk behaviour in clients of syringe-exchange schemes in England and Scotland
53. Evaluation of syringe-exchange for HIV prevention among IDUs in rural and urban areas of Wales
54. Evaluation of needle exchanges in central London: behaviour change and anti-HIV status over one year
55. Reductions in HIV risk behaviours and stable HIV prevalence in cohorts of syringe-exchange clients and other injectors in England
56. Reducing sexual transmission of HIV for injecting drug users: the challenge for counselling
57. HIV Infection in Intravenous Drug Users: a follow-up study indicating changes in risk-taking behaviour
58. Changes in HIV risk-taking behaviour in intravenous drugusers: a second follow-up
59. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow
60. Changes in the injecting risk behaviour of injecting drug users in London: 1990–1993
61. Being positive: drug injectors' experiences of HIV infection
62. Edinburgh drug users: are they injecting and sharing less?
63. Trends in HIV infection and AIDS risk behaviours among intravenous drug users in selected US cities
64. Plenary address
65. Acquired immune deficiency syndrome in England and Wales to end 1993: projections using data to end September 1989
66. The incidence and prevalence of AIDS and other severe HIV disease in England and Wales for 1992–1997: projections using data to the end of June 1992
67. The study of transitions in the route of drug use: the route from one route to another
68. AIDS and the transition to illicit drug injection—results of a randomized trial prevention program
69. Sexual behaviour of drug injectors in London: implications for HIV transmission and HIV prevention
70. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners
71. AIDS-related risk behaviour, polydrug use and temazepam
72. Sexual partners of injecting drug users: the risk of HIV infection
73. Factors associated with risk behaviour among injecting drug users
74. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment
75. Prostitute women and public health
76. Prostitutes, their Clients and Risks of HIV Infection in Birmingham
77. Continued risk behaviour among HIV positive drug injectors in London: implications for intervention
78. Knowledge about AIDS and high risk behaviour among intravenous drug users in New York City
79. The first and second decade of AIDS among injecting drug users
80. Methadone maintenance treatment in opiate dependence: a review
81. Drug dependence in prisoners
82. Women in prison and use of illicit drugs before arrest
83. Drug Abuse in Scotland: First Report
84. Buzzwords: HIV outreach glossary
85. Potential development of community oriented HIV outreach among drug injectors in the UK
86. Going beyond education to mobilising subcultural change
87. Social intervention against AIDS among injecting drug users
88. Community development as a response to HIV among drug injectors
89. Low and stable prevalence of HIV among Glasgow drug injectors
90. Reconstruction of subregional diffusion of HIV infection among injecting drug users in southeast Asia: implications for early intervention
91. HIV-1 prevalence in community-wide samples of injecting drug users in London, 1990-1993.
92. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow